Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

NCT00087542 is registered in ClinicalTrials.gov with ACADIA Pharmaceuticals Inc. as lead sponsor.

NCT NCT00087542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00087542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug
Lead sponsor
ACADIA Pharmaceuticals Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2004
Completion date
December 31, 2005
Enrollment
60
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hallucinations, parkinson's disease, psychoses